

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
He rongoā motuhake te Mepolizumab i hangaia hei āwhina i te hunga e mate ana i te huango nui me ētahi atu āhuatanga mumura kia ngāwari ake te manawa. E mahi ana tēnei rongoā werohia mā te aro ki ngā pūtau punaha ārai mate e pā ana ki te mumura i roto i ō rātou ara rererangi, e tuku ana i te tūmanako mō te hunga kāore anō i kite i te whakamaunga mai i ngā rongoā huango tuku iho.
Mēnā kei te whakaaro koe ki tēnei rongoā, kua tūtohu rānei tō tākuta, he pātai pea āu mō te āhua o tōna mahi me te aha e tūmanakohia ana. Me haere tātou i ngā mea katoa e hiahia ana koe ki te mōhio mō tēnei rongoā i roto i ngā kupu mārama, tika tonu.
He rongoā koiora te Mepolizumab e noho ana ki tētahi rōpū rongoā e kīia ana ko ngā paturopi monoclonal. Whakaarohia he rongoā tino whāinga e aro ana ki ngā kaiwhakatupu raruraru motuhake i roto i tō punaha ārai mate.
E aukati ana tēnei rongoā i tētahi pūmua e kīia ana ko interleukin-5 (IL-5), e whakahaere ana i te hanga me te mahi o ngā eosinophils. Ko ngā Eosinophils he pūtau toto mā e āwhina ana ki te whawhai i ngā mate, engari i ētahi tāngata, ka kaha rawa atu rātou, ka pā ana ki te mumura i roto i ngā pūkahukahu me ētahi atu okana.
Ka whiwhi koe i te mepolizumab hei werohanga subcutaneous, ko te tikanga ka uru ki roto i te kiko momona i raro noa iho i tō kiri. Ko te ingoa waitohu mō tēnei rongoā ko Nucala, ā, he mea hanga hei otinga e werohia ana e ngā kaiwhakarato hauora ia whā wiki.
E rongoā ana te Mepolizumab i ētahi āhuatanga nui e pā ana ki te mumura kino o te tinana e pā ana ki ngā eosinophils. Ka tūtohu pea tō tākuta i tēnei rongoā mēnā he huango nui tōu kāore e pai te whakautu ki ngā rongoā paerewa.
Ko ngā āhuatanga tuatahi e āwhina ana a mepolizumab ko te huangō eosinophilic nui, i te wā e nui ana ngā eosinophils ka uaua te whakahaere i tō huangō. Ka whakamahia hoki mō te eosinophilic granulomatosis with polyangiitis (EGPA), he āhuatanga onge e pā ana ki te mumura i roto i ngā oko toto me ngā okana.
I tua atu, ka rongoa e mepolizumab te hypereosinophilic syndrome (HES), he rōpū o ngā mate e whakaputa ana tō tinana i te nui rawa o ngā eosinophils. Ka taea hoki e tēnei rongoā te āwhina i te rhinosinusitis tawhito me ngā polyps nasal i te wā e whai wāhi ana ngā eosinophils ki te mumura.
Ka whakaaro noa tō tākuta ki te mepolizumab mēnā he nui ngā tatau eosinophil i roto i ō toto, ā, kāore anō ngā rongoā o nāianei e whakarato ana i te whakahaere tika i ō tohumate.
Ka mahi a Mepolizumab mā te mahi rite ki te aukati i te punaha ārai mate. Ka piri atu, ka whakakore i te IL-5, he karere matū e kī ana ki tō tinana kia nui ake ngā eosinophils.
Inā aukatia te IL-5, ka iti ake ngā eosinophils e whakaputaina ana e tō tinana, ā, ka iti ake te kaha o ngā mea e noho ana. Ka āwhina tēnei whakahekenga ki te whakamārie i te mumura i roto i ō ara rererangi me ētahi atu kiko e pā ana, ka māmā ake te manawa me te whakaiti i ētahi atu tohumate.
E whakaarohia ana tēnei rongoā he rongoā kaha, he rongoā motuhake e rāhui ana mō ngā tāngata e tino nui ana ngā āhuatanga. Kāore i rite ki ngā inhalers tere-āwhina e mahi ana i roto i ngā meneti, ka hanga a mepolizumab i roto i tō pūnaha i te roanga o te wā, ā, ka whakarato i te whakahaere wā-roa.
Ka kite koe i ngā whakapainga i roto i ō tohumate i muri i ētahi wiki, marama rānei o te rongoā, i te mea ka heke haere ō taumata eosinophil, ā, ka ngaro te mumura.
Ka tae mai a Mepolizumab hei syringe kua whakakiia i mua, hei autoinjector rānei ka whiwhi koe hei werohanga ia whā wiki. Mā tō kaiwhakarato hauora e hoatu ki a koe ngā werohanga tuatahi kia mōhio ai koe ki te tukanga me te aroturuki i ngā tauhohenga.
Ka haere te werohanga ki roto i te kiko ngako i raro i to kiri, i te nuinga o te wa i roto i to huha, i to ringa o runga, i to puku ranei. Ka taea e koe te huri i nga waahi werohanga hei aukati i te riri, a ka whakaako to roopu hauora i te tikanga tika ki a koe mena ka werohia koe i te kainga.
Kare koe e hiahia ki te tango i tenei rongoa me te kai, te wai ranei i te mea he werohanga, engari me ngana koe ki te whakarite i o werohanga i te wa kotahi ia marama. Kia mau tonu te rongoa ki roto i te pouaka whakamātao kia reri ra ano koe ki te whakamahi, engari kia tae ki te pāmahana rūma i mua i te werohanga.
He mea nui ki te haere tonu ki te tango i ō rongoa huango i runga i te tohutohu, ahakoa i muri i te tiimata i te mepolizumab. E mahi tahi ana tenei werohanga me ō rongoa o nāianei, ehara i te whakakapi mō rātou.
He rerekē te roa o te maimoatanga mepolizumab i runga i to ahuatanga motuhake me te pai o to urupare ki te rongoa. He maha nga tangata e haere tonu ana i tenei maimoatanga mo nga marama, tau ranei kia mau tonu ai te mana o o ratou tohu.
Ka aroturukihia e tō tākuta ō taumata eosinophil me ō tohu i ngā wā katoa hei whakatau mēnā kei te pai te mahi o te rongoa. Mena kei te kite koe i nga hua pai, ka haere tonu koe i te maimoatanga mo te wa roa, na te mea ko te whakamutu i te mepolizumab ka hoki mai ano nga tohu.
Ka taea e etahi tangata te whakaiti i te auau o nga werohanga, i te mutunga ranei ka mutu te maimoatanga mena ka pai ake to ratou ahua. Heoi, me whakatau tonu tenei whakatau i runga i te korero tata ki to kaiwhakarato hauora.
He mea nui nga huihuinga whai-ake i nga wa katoa ki te arotake i to ahunga whakamua me te whakatika i to mahere maimoatanga i te mea e tika ana. Ka tohutohu pea tō tākuta ki te whakamutu i te mepolizumab mena karekau koe e kite i nga painga i muri i nga marama maha, mena ka puta nga paanga taha e pa ana ki a koe.
Pērā i ngā rongoā katoa, ka pānga ngā pānga taha ki te mepolizumab, ahakoa he maha ngā tāngata e pai ana ki te tango. Ko ngā pānga taha tino noa he ngawari noa iho, ā, ka taea te whakahaere mā te tiaki tika.
Koinei ngā pānga taha ka pā ki a koe, ka tīmata mai i ngā mea tino noa:
Ko ēnei pānga taha noa ka pai ake i a rātou anō, ā, kāore e hiahiatia te whakamutu i te rongoā. Heoi anō, me kōrero tonu koe i ngā tohumate e mau tonu ana, e whakararuraru ana rānei ki tō tākuta.
Ka pā ki ētahi tāngata ngā pānga taha nui ake, engari he iti noa iho te noa, e hiahia ana kia āta tirohia e te tākuta. Kei roto i ēnei ko ngā tauhohenga mate pāwera nui me ngā tohumate pērā i te uaua ki te hā, te pūpū o tō mata, o tō korokoro rānei, te pūwhaowhao whānui rānei.
Ko ngā pānga taha onge, engari he nui, ka uru ki ngā mate nui, i te mea ka pānga te mepolizumab ki tō pūnaha ārai mate. Ka pā ki a koe te hūpē (herpes zoster) te whakahāngai anō, ētahi atu mate whai wāhi rānei i ngā wā onge rawa.
Mēnā ka kite koe i ngā tohumate rerekē, te kirika e mau tonu ana, ngā tohu rānei o te mate, whakapā atu ki tō tākuta i te wā tonu. Ka taea e rātou te āwhina ki te whakatau mēnā e pā ana ēnei tohumate ki tō rongoā, me te whakatika i tō maimoatanga mēnā e tika ana.
Kāore te Mepolizumab e tika ana mō te katoa, ā, ko ētahi āhuatanga hauora, āhuatanga rānei ka kore e tika, ka mōrearea rānei tēnei rongoā. Ka āta arotakehia e tō tākuta tō hītori hauora i mua i te whakahau.
Kaua koe e tango i te mepolizumab mēnā i pā koe i tētahi pānga mate pāwera nui ki tēnei rongoā, ki ōna whakauru rānei i mua. Ko ngā tāngata e pangia ana e ngā mate pāwera e kore e rongoatia, me karo hoki i tēnei rongoā kia mārama rā anō tō rātou mate.
Ko ngā wāhi e kore ai e tūtohutia te mepolizumab:
Mēnā kei te whāngai ū koe, kei te hapū, kei te whakamahere rānei koe kia hapū, kōrerohia tēnei ki tō tākuta. Ahakoa kāore anō i tino rangahaua te mepolizumab i roto i ngā wāhine hapū, ka āwhina tō kaiwhakarato hauora ki te whakatau i ngā painga pea ki ngā tūponotanga.
Ko ngā tamariki kei raro i te 6 tau te pakeke kāore i te whiwhi i te mepolizumab, nā te mea kāore anō i whakatauhia te haumaru me te whai huatanga mō ngā tamariki tino pōtiki. Ka whakaaro tō tākuta ki tō tau, ki tō hauora whānui, me tō āhuatanga motuhake i te wā e whakatau ana mēnā he tika tēnei rongoā mōu.
Kei te wātea te Mepolizumab i raro i te ingoa waitohu Nucala i te nuinga o ngā whenua, tae atu ki te United States, Canada, me Europe. Koinei anake te ingoa waitohu e wātea ana mō tēnei rongoā.
He rerekē ngā hanganga o te Nucala, tae atu ki ngā syringe kua whakakiia i mua, me ngā autoinjectors, i runga i ō hiahia me ō manakohanga. Ka āwhina tō kaiwhakarato hauora i a koe ki te whiriwhiri i te kōwhiringa e tika ana i runga i tō taumata whakamarie ki te werohanga whaiaro me tō horopeta kua whakaritea.
Kāore anō he putanga generic o te mepolizumab e wātea ana, nā te mea kei te tiakina tonu tēnei rongoā e ngā patent. Ko te tikanga ko Nucala anake te huarahi ki te uru atu ki tēnei rongoā motuhake.
He maha atu ngā rongoā koiora e mahi ana i te ara rite ki te mepolizumab mō te rongoā i te huangō kaha me ngā āhuatanga eosinophilic. Ka whakaaro pea tō tākuta i ēnei kōwhiringa mēnā kāore te mepolizumab i te tika mōu, kāore rānei e whai hua ana ki te whakahaere i ngā tohumate.
Ko ētahi atu rongoā anti-IL-5 ko te benralizumab (Fasenra), e mahi ana mā te whai i te kaiwhakawhiwhi IL-5, me te reslizumab (Cinqair), e aukati ana i te IL-5 pērā i te mepolizumab engari ka tukuna mā te uaua. He rite tonu te mahi o ēnei rongoā engari he rerekē ngā hōtaka inenga me ngā tikanga whakahaere.
Mō te huangō kaha, ka whakaaro pea tō tākuta ki te omalizumab (Xolair), e whai ana i ngā paturopi IgE, ki te dupilumab (Dupixent), e aukati ana i ngā ara mumura rerekē. Ka whakawhirinaki te kōwhiri ki tō momo huangō me ō tauira urupare takitahi.
Ko ngā rongoā tuku iho pērā i ngā corticosteroids i te horopeta nui, ngā bronchodilators e mahi ana mō te wā roa, me ngā corticosteroids waha, he wāhanga nui tonu o ngā mahere rongoā. Ka mahi tō tākuta ki a koe ki te kimi i te huinga rongoā e whai hua ana ki te whakahaere i ngā tohumate me te iti rawa o ngā pānga taha.
He rongoā koiora whai hua te Mepolizumab me te omalizumab mō te huangō kaha, engari he rerekē te mahi me te pai ake mō ngā momo tūroro rerekē. Kāore tētahi rongoā i te whānui ake i te
He rerekē anō ngā hōtaka horopeta, ka hoatu te mepolizumab ia marama, ā, ka hoatu te omalizumab ia 2-4 wiki i runga i tō horopeta. Ko ō hiahia oranga me te pai ki te auau werohanga ka pā ki te kōwhiringa e pai ana ki a koe.
He haumaru te mepolizumab mō te hunga mate huka, nā te mea kāore e pā tika ana ki ngā taumata huka toto, e raru ana rānei i ngā rongoā mate huka. Heoi anō, me whakamōhio tonu koe ki tō kaiwhakarato hauora mō tō mate huka i te wā e tīmata ana i tētahi rongoā hou.
Ko ētahi tāngata mate huka tērā pea he paku teitei ake te tūponotanga o ngā mate, he mea pea tēnei e tika ana kia whakaarohia nā te mea e pā ana te mepolizumab ki tō pūnaha ārai mate. Ka mātakitaki tata tō tākuta i a koe, ā, tērā pea ka tūtohu i ētahi atu whakatūpato hei ārai i ngā mate.
Mēnā ka werohia e koe te nui rawa o te mepolizumab, whakapā atu ki tō kaiwhakarato hauora, rapu rānei i te āwhina hauora tonu. Ahakoa he onge te nui rawa o te horopeta ki tēnei rongoā, he mea nui kia whiwhi tohutohu ngaio.
Kaua e ngana ki te
Me mutu anake tō tango mepolizumab i raro i te tohutohu a tō kaiwhakarato hauora. He maha ngā tāngata e hiahia ana ki te haere tonu i tēnei rongoā mō te wā roa kia mau tonu ai te mana o ā rātou tohumate, ā, ko te whakamutu ohorere ka hoki mai te mumura me ngā tohumate.
Ka arotakehia e tō tākuta tō ahunga whakamua i ngā wā katoa, ā, ka whakaaro pea ki te whakaiti i te auau o ngā werohanga, ki te whakamutu rānei i te rongoā mēnā kua pai ake tō āhuatanga, ā, kua tū tonu mō te wā roa. E whakawhirinaki ana tēnei whakatau ki tō urupare takitahi me te āhuatanga e rongoatia ana.
Āe, ka taea e koe te haere i te wā e tango ana koe i te mepolizumab, engari me whakamahere i mua kia mau tonu ai tō hōtaka werohanga. Mēnā kei te haere koe i te wā o te werohanga kua whakaritea, mahi tahi me tō kaiwhakarato hauora ki te whakarite i te rongoā i tō ūnga, ki te whakatika rānei i tō hōtaka.
I te wā e haere ana koe me te mepolizumab, waiho te rongoā ki te pouaka whakamātao, ā, mau mai he reta mai i tō tākuta e whakamārama ana i tō hiahia hauora mō te werohanga. Ka hiahia pea ngā āpiha haumaru rererangi me ngā āpiha tikanga kia whakapūmau kei te mau ana koe i te rongoā tūturu mō te whakamahi hauora whaiaro.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.